AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bio Green Med Solution, Inc. Director's Dealing 2017

Feb 27, 2017

35092_dirs_2017-02-27_15a77065-9ddd-433a-a24d-4bec2384758e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2017-02-23

Reporting Person: TANG KEVIN C (10% Owner)
Reporting Person: TANG CAPITAL MANAGEMENT LLC (10% Owner)
Reporting Person: TANG CAPITAL PARTNERS LP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	425700	Indirect

Footnotes

F1: The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP. Mr. Tang disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein.